Health unions in pay talks with SA government speak out about ongoing healthcare challenges
Three-and-a-half years after Labor was elected on a promise to fix the ramping crisis, one of the state's key health unions had a message for the South Australian government.
"We are sick and tired of being placated and told that people are working on things," Ms Dabars said, flanked by a group of members in scrubs.
The union this week went public with concerns over what it calls "internal ramping" — the practice of caring for patients in makeshift areas because no bed is available.
Asked about what had prompted her to speak out about the issue, Ms Dabars said she had spent months trying to work with the government behind closed doors — to no avail.
"We have tried every single avenue humanly open to us to resolve this concern," she said.
Health Minister Chris Picton fired back, responding "we don't accept that terminology from the trade union" — while SA Health claimed it was standard practice to care for patients in alternative spaces while they wait for a bed.
The nurses are not the only health workers to have aired their concerns publicly in recent weeks.
The unions representing doctors and paramedics have also criticised the government over its handling of issues including ramping, hospital overcrowding and safety.
Ambulance Employees Association secretary Paul Ekkelboom this week raised issues of ramping and resourcing in the wake of the death of a man involved in a car crash at Sellicks Hill.
SA Salaried Medical Officers' Association (SASMOA) chief industrial officer, Bernadette Mulholland, has highlighted safety concerns over working conditions inside hospitals.
In most cases, a union boss calling out the government is hardly remarkable.
Yet, for much of Labor's term, health unions faced criticism for keeping too low a profile as ramping hours climbed and the system struggled to cope under enormous strain.
The relative silence was most stark in the case of the Ambulance Employees' Association, which had played a key role in helping to turf out the previous Liberal government and get Labor into office.
The union helped the then-opposition to humanise the ramping crisis — raising the cases of victims and speaking out about the toll ramping takes on paramedics.
"Ash the Ambo" became the face of the campaign, issuing a powerful warning to "vote Labor like your life depends on it".
Following the election, the union faced accusations it was failing to hold Labor to the same standard it had the Liberals.
Even as ramping continued to reach eye-watering levels, former secretary Leah Watkins showed a more sympathetic approach to the new government — insisting in interviews it would take time for Labor's funding boost to alleviate pressure on the system.
Mr Ekkelboom was installed last year as union secretary, thoroughly defeating Ms Watkins after promising to re-establish the AEA's "political independence" and take a "stronger stance" on ramping.
The increasing union loudness comes at a time where doctors, nurses and paramedics are all in the midst of pay negotiations, some of which are threatening to turn hostile.
The Australian Nursing and Midwifery Federation said discussions with the government are continuing, while the doctors have already held a stop-work meeting and are planning a strike later this month.
SASMOA wants 10 per cent annual pay increases over the next three years — a demand the government has called untenable.
Bosses have been quick to shut down any link between their recent criticism and the ongoing pay talks.
"Let me be very clear. This is nothing to do with that," Ms Dabars said on Wednesday.
Mr Ekkelboom said it would be disrespectful to make any comment on his union's wage negotiations while he was speaking out about the death of a patient.
But public commentary is one of the most powerful tools at the unions' disposal — and one some are using now more than at any other point in this term of government.
It's been a quieter couple of weeks for the Health Services Union, which earlier this month reached a deal with the government on their new enterprise agreement.
Eight months out from the next state election, Labor is widely considered by politicians and pundits to be overwhelming favourites to win another term in office.
With a popular premier and an opposition struggling to land punches, there seem to be only a small handful of issues with the potential to inflict real damage on Labor between now and March.
Whether the difficulty the government has faced to deliver on its promise to fix the ramping crisis is one of those potential banana skins remains to be seen.
Public concern around the state of the health system is not at the same level it was in 2022, when Labor was swept to power on the back of its ramping pledge.
But the state's health unions hold the power to change that — and, whatever their motivation, they're looking ready to use it.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Australian
9 hours ago
- The Australian
Spike in adverse event reports for ADHD medication Vyvanse
Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' The TGA issued an alert about a typo on the Vyvanse label earlier this year. Picture: TGA 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Last year, 1.8m Vyvanse prescriptions were written in Australia, excluding Department of Veterans' Affairs patients, over-the-counter drugs, private prescriptions and public inpatient prescriptions. Picture: NewsWire / Martin Ollman Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said. Blair Jackson Reporter Blair's journalism career has taken him from Perth, to New Zealand, Queensland and now Melbourne. Blair Jackson
News.com.au
13 hours ago
- News.com.au
Spike in ADHD medication adverse event reports
Authorities are investigating a spike in incidents involving one of Australia's most widely used ADHD medications. Adverse event reports linked to medication Vyvanse have spiked massively this year, and the manufacturer says no changes in the chemical production have been made. 'The Therapeutic Goods Administration (TGA) is currently investigating a potential safety signal associated with Vyvanse, including independent testing of the medicine through the TGA Laboratories,' a spokesperson told NewsWire. 'The investigation is the result of a recent increase in adverse event notifications relating to concerns about the quality, safety, and reduced effectiveness of the drug.' 'There are no compliance signals currently under investigation for the facilities used in the manufacture of this product.' A 'signal' is detection of a pattern which requires further investigation. While not formally a pattern in the TGA's eyes, reports of adverse events such as anxiety, ineffectiveness and insomnia have increased massively this year. There have also been 88 reports of issues with the medicines label, which was flagged by the TGA earlier this year for minor typos; however, one of the typos added an extra 'S' to the word capsule; 'Each capsules contains 60mg lisdexamfetamine dimesilate'. The TGA maintains the Database of Adverse Event Notifications, where people report issues with medications. There have been 320 adverse events linked to Vyvanse in the first half of this year, compared to nine reports in the second half of 2024. Inclusion in the database does not confirm the incident is caused by the medication. Reports of ineffective Vyvanse have hit 150 so far this year, along with 88 reports of anxiety, and 73 reports that the therapeutic response has decreased. Prescriptions of Vyvanse have been steadily increasing for the past few years. More than 958,000 scripts were written by public system health workers in 2022, rising to 1.4 million in 2023, and then 1.8m last year, government data shows. In a statement, supplier Takeda Pharmaceuticals Australia said a change of manufacturing facility in 2024 did not alter the chemical composition of the medicine. 'There have been no changes to the formulation,' a Takeda spokesperson told the ABC. Vyvanse was produced with strict quality controls, in line with Australia's Therapeutics Goods Act, the spokesperson said. The labelling typo did not affect the quality of the medication, they said.
News.com.au
15 hours ago
- News.com.au
Measles alert issued across NT airports, tourism hotspots
Northern Territory health authorities have issued a measles alert after a man travelled through multiple tourism hotspots before ending up in hospital in north Queensland. NT Health issued the alert on Saturday morning, warning anyone who was on tourism trips in the state, at restaurant in Kakadu National Park, or travelled through Darwin or Alice Springs Airports on specific dates in July to be alert for measles symptoms. These include a fever, sore eyes, a runny nose, a cough, and a blotchy red rash. 'Check your vaccination status,' an NT Health spokesperson said. 'Measles is highly contagious but preventable with two doses of a measles-containing vaccine.' Health authorities suspect the man who travelled while infectious acquired measles in Indonesia. 'The NT Centre for Disease Control is urging Territorians to be alert following confirmation of a measles case who travelled through Darwin and Alice Springs while infectious,' the alert reads. 'The individual, likely infected overseas, visited multiple public locations in the NT between July 17 and 23.' NT Health says the man was likely infectious when he went on an all-day tour with Ethical Adventures in Litchfield National Park on July 17. The next day, he left for an overnight tour with AAPT Kings Jabiru, and was at the Mercure Kakadu Crocodile Hotel in Jabiru from 6pm to 8pm on July 18. The measles alert does not account for his movements the next two days, but the next listed location is the Museum and Art Gallery of the Northern Territory, from 1pm to 3pm on July 20. It is believed the man then went to Darwin Airport at 3.30pm and flew to Alice Springs on Qantas flight QF1960, arriving at 7pm. On Wednesday, July 23, the man flew from Alice Springs to Cairns on Air North flight TL361. 'Anyone who attended these locations during these times should monitor for symptoms … Symptoms can take up to 18 days after exposure to develop,' the alert said. 'The vaccine is safe and effective, and available from your GP, local health centre, Aboriginal health clinic, and vaccinating pharmacies.'
